PALMITOYLETHANOLAMIDE,BOSWELLIA,PINE BARK EXTRACT

Palmitoylethanolamide (PEA), Boswellia, and Pine Bark Extract are recognised for their combined effects in managing inflammation and chronic pain. PEA, a naturally occurring fatty acid amide, was first identified in the 1950s. Clinical studies have demonstrated its effectiveness in modulating inflammation and neuropathic pain. Boswellia, derived from the resin of Boswellia serrata, has been used in traditional medicine for centuries for its anti-inflammatory properties. Pine Bark Extract, rich in polyphenols and proanthocyanidins, has been studied extensively for its antioxidant and vascular benefits. These compounds are classified as nutraceuticals or dietary supplements in many countries, with regulatory approval varying by region. PEA has been used as a dietary supplement since the early 2000s and is frequently included in combination therapies for pain relief. Boswellia and Pine Bark Extract have a long history of use in herbal medicine, with clinical trials supporting their role in joint and cardiovascular health.

This combination is widely used in: Neuropathic pain management (e.g., sciatica, carpal tunnel syndrome). Joint health, including osteoarthritis and rheumatoid arthritis. Inflammatory conditions such as asthma and inflammatory bowel disease. Cardiovascular support through improved circulation and reduced oxidative stress.

The formulation is typically available in combination capsules or tablets. Depending on the severity of the condition and patient response, 600–1200 mg/day of the combined formula is divided into 2-3 doses. A healthcare provider may adjust the dosage for specific conditions, such as chronic pain or inflammatory disorders. Always adhere to the dosage instructions on the product label or consult a medical professional.

Generally well-tolerated when taken at recommended dosages. Potential side effects include: Mild gastrointestinal upset (e.g., nausea, bloating). Allergic reactions (rare). Headache or dizziness in sensitive individuals.

It is not suitable for individuals with hypersensitivity to any of the ingredients. It may interact with anticoagulants or anti-inflammatory medications. Avoid use during pregnancy or breastfeeding unless directed by a healthcare provider.

Consult a doctor before use, especially for individuals with chronic illnesses such as liver or kidney disease. Discontinue use if allergic reactions or gastrointestinal discomfort occur. Monitor for potential drug interactions if taking other medications.

This combination is formulated to address inflammation and chronic pain, offering an alternative for patients seeking to avoid prolonged NSAID use and its associated risks. Selection from established manufacturers with verified ingredient quality is advisable. Dosage determination and assessment of compatibility with concurrent medications should be undertaken by a qualified healthcare professional.

Tafuri A, Panunzio A, De Mitri R, Benetti F, Gaio E, Pagliarulo V. Micronized Palmitoylethanolamide, Hempseed Oil, and Maritime Pine Bark Dry Extract (Pelvipea®) for Pelvic Pain: An In Vitro Study for Urothelial Inflammation Treatment. Cells. 2023 Feb 14;12(4) https://pmc.ncbi.nlm.nih.gov/articles/PMC9953806/ https://www.webmd.com/vitamins/ai/ingredientmono-1596/palmitoylethanolamide-pea https://leohb.com/combination-ingredients/boswellia-p-e-a/